Aqualane Clinical Research is a comprehensive group that advances medical therapies in various human disease states. We allow patients to participate in discovering treatments where none currently exist or where there is an unmet need for safety and more effectiveness. By collaborating with our patients, their care partners, and industry sponsors, we focus on the safe and ethical study of these emerging therapies.
At Aqualane, we always put our patients first.
We promise to educate each potential participant and their family members on all available options and support them in their decision-making process. Striving to make clinical trials practical healthcare, we provide a comfortable, caring, and compassionate environment.
Our founders, Dr. William Justiz, Dr. Matthew Baker, and Kelly Calistri, are passionate about their contributions to the advancement of medicine and the opportunities they provide to people searching for new treatment options. With expertise and experience in research and the central nervous system, you can trust our team of neurologists and researchers to provide the best possible opportunity for you or your loved one.
Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), including the brain and spinal cord. In MS, the body’s immune system mistakenly attacks the myelin sheath, the protective covering of nerve fibers, causing inflammation and damage. This damage disrupts the normal flow of electrical impulses along the nerves, leading to a wide range of symptoms, including muscle weakness, fatigue, vision problems, and difficulties with coordination and balance.
According to the National Multiple Sclerosis Society, MS affects approximately 2.8 million people worldwide, with around 1 million individuals affected in the United States alone. It is more common in women than men, with onset typically occurring between 20 and 40, although it can occur at any age.
Remyelination is the process by which damaged myelin is repaired or replaced. This process is crucial in MS because it can help restore nerve function and alleviate symptoms. Research into remyelination has been a focus of much scientific interest and holds promise for developing new treatments for MS.
Clinical research studies are vital in advancing our understanding of MS and developing new treatments. Here are some reasons why a newly diagnosed patient might want to consider participating in a clinical research study:
1. Access to New Treatments: Clinical trials offer cutting-edge treatments that may not be available to the general public. By participating in a trial, patients can receive innovative therapies that could potentially improve their condition.
2. Contribution to Science: By participating in a clinical trial, patients contribute to advancing medical knowledge and developing new treatments for MS. Their involvement helps researchers gather data and evaluate the effectiveness and safety of potential therapies.
3. Comprehensive Care: Clinical trials often provide participants with comprehensive care and close monitoring by medical professionals. This can include regular check-ups, diagnostic tests, and access to experts in MS care, ensuring that participants receive high-quality medical attention throughout the study.
4. Personalized Treatment: Some clinical trials focus on personalized medicine approaches, tailoring treatments to individual patients based on their unique characteristics. Participating in such trials may allow patients to receive personalized care specifically tailored to their needs.
5. Hope for the Future: By participating in a clinical trial, patients become part of a community working towards finding better treatments and, ultimately, a cure for MS. This can provide a sense of hope and empowerment, knowing that they are contributing to a cause that may benefit future generations of MS patients.
Patients considering participating in a clinical research study should discuss the potential risks and benefits with their healthcare provider and carefully weigh their options. Additionally, patients should ensure they fully understand the study protocol, including any potential side effects or inconveniences associated with participation.
Aqualane Clinical Research has trials open for people with:
. Alzheimer’s Disease
. Parkinson’s Disease
. Multiple Sclerosis
. Myasthenia Gravis
. Essential Tremor
. Multiple System Atrophy
. Migraine
. Depression
. Anxiety
. Other Neuropsychiatric Conditions
239-529-6780
3200 Bailey Lane • Suite 180 • Naples, FL 34105
www.aqualaneresearch.com